Tyrosine Phosphorylation Inhibits PKM2 to Promote the Warburg Effect and Tumor Growth
Top Cited Papers
- 17 November 2009
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science Signaling
- Vol. 2 (97), ra73
- https://doi.org/10.1126/scisignal.2000431
Abstract
Tyrosine phosphorylation of pyruvate kinase M2 gives tumor cells a metabolic advantage.Keywords
This publication has 28 references indexed in Scilit:
- Fibroblast Growth Factor (FGF) and FGF Receptor-Mediated Autocrine Signaling in Non-Small-Cell Lung Cancer CellsMolecular Pharmacology, 2008
- Modulation of M2‐type pyruvate kinase activity by the cytoplasmic PML tumor suppressor proteinGenes to Cells, 2008
- Current Status of Tumor M2 Pyruvate Kinase (Tumor M2-PK) as a Biomarker of Gastrointestinal MalignancyAnnals of Surgical Oncology, 2007
- Hypoxia signalling controls metabolic demandCurrent Opinion in Cell Biology, 2007
- Tumour M2-pyruvate kinase: a gastrointestinal cancer markerEuropean Journal of Gastroenterology & Hepatology, 2007
- Pyruvate kinase type M2 and its role in tumor growth and spreadingSeminars in Cancer Biology, 2005
- Immunoaffinity profiling of tyrosine phosphorylation in cancer cellsNature Biotechnology, 2005
- The Hallmarks of CancerCell, 2000
- FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndromeNature Genetics, 1998
- The allosteric regulation of pyruvate kinaseFEBS Letters, 1996